Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitors
Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitorsDiet can impact anticancer drug activity. A classic example in rodents is a ketogenic diet enhancing PI3K inhibitor activity. Here, we show that phytochemicals and their microbiome derivatives, rather than macronutrient composition, underlie this phenomenon.Diet can impact anticancer drug activity. A classic example in rodents is a ketogenic diet enhancing PI3K inhibitor activity. Here, we show that phytochemicals and their microbiome derivatives, rather than macronutrient composition, underlie this phenomenon.Asael Roichman, Qianying Zuo, Sunghoon Hwang, Wenyun Lu, Ricardo A. Cordova, Michael R. MacArthur, Jacob A. Boyer, Sarah J. Mitchell, Jesse Powers, Sophia A. Koval, Craig J. Hunter, Jamie Rijmers, Rolf-Peter Ryseck, Jenna E. AbuSalim, Seema Chatterjee, Won Dong Lee, Xincheng Xu, Xi Xing, Zihong Chen, Xianfeng Zeng, Siddharth Marwaha, Matthew J. McBride, Jessie Y. Guo, Yibin Kang, Mohamed S. Donia, Joshua D. Rabinowitzhttps://www.cell.com/cell/fulltext/S0092-8674(25)00511-2?rss=yeshttp://www.cell.com/cell/inpress.rssCellCell RSS feed.Wireless News CampaignMay 20, 2025
Powered by WPeMatico